News
According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.39%, which ...
1d
Investor's Business Daily on MSNGlobus Medical Sees Relative Strength Rating Improve To 73Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...
StockStory.org on MSN1d
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...
AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March ...
OTTAWA - A Conservative government would keep the country's medical assistance in dying regime intact, Pierre Poilievre said Saturday, but it is not looking to follow Quebec's lead in allowing ...
Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...
On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts' stance ...
On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results